Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Exploring new spinal cord stimulation methods for chronic pain relief

Official title: Mechanisms and Outcome-Prognostication for Paresthesia-based and -Free Spinal Cord Stimulation in Patients With Persistent Neuropathic Pain: the MOPPStim Study

Run by University Health Network, Toronto · NCT03852381 · Data updated 2026-11-12

This study is testing new ways of using spinal cord stimulation to see if they can help people with chronic pain feel better compared to traditional methods.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment90 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedMay 16, 2019
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 15, 2026
Trial IDNCT03852381 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 80 with refractory neuropathic pain following lumbar spine surgery.

Probably not a fit

Patients with previous spinal cord stimulation trials or those with certain medical contraindications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of different spinal cord stimulation (SCS) methods, specifically comparing traditional paresthesia-based SCS with newer paresthesia-free SCS techniques. It aims to understand the mechanisms behind pain relief and identify which patients are most likely to benefit from these treatments. Participants will undergo neuroimaging and assessments to gather data on pain, physical activity, and sleep patterns. The study is designed to be prospective and exploratory, with randomization and blinding to ensure robust results.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management options for patients suffering from chronic neuropathic pain.

How similar studies have gone: While traditional spinal cord stimulation has been widely used, the newer paresthesia-free methods are relatively novel and have not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults, 18 - 80 years of age, with refractory neuropathic pain (as per clinical features and DN4 score \> 3/10) in back and or lower limbs for more than 3 months following lumbar spine surgery
2. Severity of pain \> 3/10 on NRS and ODI score for disability \>40/100; and
3. Pain refractory to conventional medical management tried for at least 3 months.

Exclusion Criteria:

1. Age \< 18 or age ≥ 80 years;
2. Previous trial or implantation of SCS system;
3. Procedural contraindications to SCS including extensive thoracolumbar spine surgery, moderate-to-severe central canal stenosis, coagulopathy, local or systemic infection;
4. Pregnancy;
5. Opioid dose \> 200 mg OMED;
6. Psychiatric or psychological disorder likely to impact perception of pain;
7. Inability to comply with the study interventions or evaluate treatment outcomes;
8. Mechanical spine instability as per flexion/extension lumbar X-rays;
9. Ongoing litigation issues related to the pain; and
10. Concomitant peripheral neuropathy or myopathy or central neuropathic pain (e.g. post-stroke pain).

Where it's running

  • Toronto Western Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Anuj Bhatia, MD FRCPC — University Health Network, Toronto
  • Study coordinator: Anuj Bhatia, MD FRCPC
  • Email: anuj.bhatia@uhn.ca
  • Phone: (416) 603-5800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.